- Press release
3
min time reading
2025 first quarter sales: Strong start to the year, demonstrating the relevance of our health-oriented portfolio
- Corporate news
- Strong Q1 2025, with sales of €6,844m, up +4.3% on a like-for-like (LFL) basis
- Contributions from both volume/mix (+1.9%) and price (+2.4%); positive volume/mix again in all categories
- Broad-based growth, demonstrating the resilience of our business
- Very strong performance in China, North Asia & Oceania, in all categories
- Solid growth in North America, led by a continued, winning momentum in High Protein
- Consistent progress in Europe with solid volume/mix
- 2025 guidance confirmed, in line with mid-term ambition: LFL sales growth expected between +3% and +5%, with recurring operating income growing faster than sales
Access to the full Press Release here
Press releases
Contacts
| Press | |
|---|---|
| Investors | investors.relations@danone.com |
| Danone Ethics Line | www.danoneethicsline.com |
| Customers | Contact your local team |
| Candidates | Apply here |